Added to YB: 2025-01-14
Pitch date: 2025-01-11
TMO [bullish]
Thermo Fisher Scientific Inc.
+13.43%
current return
Author Info
Rijnberk InvestInsights shares market-leading companies and top investment ideas through concise, high-conviction analysis. Sign up for the newsletter.
Company Info
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.
Market Cap
$194.5B
Pitch Price
$540.91
Price Target
668.00 (+9%)
Dividend
0.36%
EV/EBITDA
19.95
P/E
28.77
EV/Sales
5.19
Sector
Life Sciences Tools and Services
Category
growth
Thermo Fisher Scientific Inc. – Uniquely positioned for long-term success (A Deep Dive)
TMO: High-quality compounder in healthcare/pharma. 83% recurring revenue, 15% market share. 7-9% long-term revenue CAGR, mid-teens EPS growth. Strong moat, M&A focus. Q3 flat revenue but accelerating growth. $668 price target for 2026, 11% annual return potential. Buy below $540-550.
Read full article (14 min)